Study reveals why some women with deadly ovarian cancer respond better to treatment than others

You win some, you lose some: As­traZeneca’s block­buster can­cer med­i­cine Imfinzi has suc­ceed­ed in a late-stage blad­der can­cer tri­al, but dis­ap­point­ed in a sep­a­rate Phase

Share this article The development of biological drugs such as gene and cell therapies and vaccines is boosting the production of injectable drug products in